Histone lactylation as a driver of metabolic reprogramming and immune evasion

Lactate is the end product of glycolysis, and extensive research has shown that lactate participates in various pathophysiological processes. Along with associated hydrogen ions, lactate typically functions as an immunosuppressive negative factor and plays a crucial role in tumor metabolic reprogram...

Full description

Saved in:
Bibliographic Details
Main Authors: Cai Qiaoting, Deng Wei, Zou Yutian, Chen Zhe-Sheng, Tang Hailin
Format: Article
Language:English
Published: De Gruyter 2024-12-01
Series:Medical Review
Subjects:
Online Access:https://doi.org/10.1515/mr-2024-0091
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849428864826081280
author Cai Qiaoting
Deng Wei
Zou Yutian
Chen Zhe-Sheng
Tang Hailin
author_facet Cai Qiaoting
Deng Wei
Zou Yutian
Chen Zhe-Sheng
Tang Hailin
author_sort Cai Qiaoting
collection DOAJ
description Lactate is the end product of glycolysis, and extensive research has shown that lactate participates in various pathophysiological processes. Along with associated hydrogen ions, lactate typically functions as an immunosuppressive negative factor and plays a crucial role in tumor metabolic reprogramming. The recently discovered lactylation is a novel epigenetic modification that, similar to other epigenetic modifications, modifies histones to alter chromatin spatial configuration, thereby affecting DNA accessibility and regulating gene expression. More importantly, the degree of lactylation is closely related to local lactate concentrations, establishing a link between epigenetics and metabolic reprogramming. During cellular metabolism, lactate accumulation promotes histone lysine lactylation in cancer cells and immune cells such as macrophages and T cells, playing an essential role in tumor immune evasion and resistance to immunotherapy. This paper details the role of lactylation modifications in cancer immune evasion and resistance to immunotherapy, providing novel therapeutic directions and targets for cancer treatment.
format Article
id doaj-art-d6aea56ea07c40d0b1a9ebbd86894f77
institution Kabale University
issn 2749-9642
language English
publishDate 2024-12-01
publisher De Gruyter
record_format Article
series Medical Review
spelling doaj-art-d6aea56ea07c40d0b1a9ebbd86894f772025-08-20T03:28:32ZengDe GruyterMedical Review2749-96422024-12-015325625910.1515/mr-2024-0091Histone lactylation as a driver of metabolic reprogramming and immune evasionCai Qiaoting0Deng Wei1Zou Yutian2Chen Zhe-Sheng3Tang Hailin4State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, ChinaCollege of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USAState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, ChinaLactate is the end product of glycolysis, and extensive research has shown that lactate participates in various pathophysiological processes. Along with associated hydrogen ions, lactate typically functions as an immunosuppressive negative factor and plays a crucial role in tumor metabolic reprogramming. The recently discovered lactylation is a novel epigenetic modification that, similar to other epigenetic modifications, modifies histones to alter chromatin spatial configuration, thereby affecting DNA accessibility and regulating gene expression. More importantly, the degree of lactylation is closely related to local lactate concentrations, establishing a link between epigenetics and metabolic reprogramming. During cellular metabolism, lactate accumulation promotes histone lysine lactylation in cancer cells and immune cells such as macrophages and T cells, playing an essential role in tumor immune evasion and resistance to immunotherapy. This paper details the role of lactylation modifications in cancer immune evasion and resistance to immunotherapy, providing novel therapeutic directions and targets for cancer treatment.https://doi.org/10.1515/mr-2024-0091cancerimmune escapehistone lactylationimmunotherapy resistance
spellingShingle Cai Qiaoting
Deng Wei
Zou Yutian
Chen Zhe-Sheng
Tang Hailin
Histone lactylation as a driver of metabolic reprogramming and immune evasion
Medical Review
cancer
immune escape
histone lactylation
immunotherapy resistance
title Histone lactylation as a driver of metabolic reprogramming and immune evasion
title_full Histone lactylation as a driver of metabolic reprogramming and immune evasion
title_fullStr Histone lactylation as a driver of metabolic reprogramming and immune evasion
title_full_unstemmed Histone lactylation as a driver of metabolic reprogramming and immune evasion
title_short Histone lactylation as a driver of metabolic reprogramming and immune evasion
title_sort histone lactylation as a driver of metabolic reprogramming and immune evasion
topic cancer
immune escape
histone lactylation
immunotherapy resistance
url https://doi.org/10.1515/mr-2024-0091
work_keys_str_mv AT caiqiaoting histonelactylationasadriverofmetabolicreprogrammingandimmuneevasion
AT dengwei histonelactylationasadriverofmetabolicreprogrammingandimmuneevasion
AT zouyutian histonelactylationasadriverofmetabolicreprogrammingandimmuneevasion
AT chenzhesheng histonelactylationasadriverofmetabolicreprogrammingandimmuneevasion
AT tanghailin histonelactylationasadriverofmetabolicreprogrammingandimmuneevasion